Skip to main content
Caplight Logo









AIBLE Therapeutics

AIBLE Therapeutics

Private
SeoulHealthcare & Life Scienceshttps://aible.co.kr/

Last Round

Early Funding

Nov 1, 2023

Company Overview

AIBLE Therapeutics is a digital health company that develops AI-powered mobile applications for the screening, diagnosis, and management of neuropsychiatric disorders such as dementia.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Mental Health, Medical Devices, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

digital therapeuticsDTxdementia screeningAI voice analysiscognitive impairmenthealth techmedical AIcognitive trainingmobile diagnostic toolspeech biomarkerremote patient monitoringRPMSaaSgeriatric careAI diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AIBLE Therapeutics Comparables

Compare AIBLE Therapeutics with similar companies based on industry and business-model similarity.

AIBLE Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Seven Point One
90%
Voinosis
88%
Silvia Health Inc.
87%

AIBLE Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingNov 1, 2023
VC RoundDec 1, 2022
SeedOct 1, 2021

AIBLE Therapeutics Investors

Notable investors and investment history

AIBLE Therapeutics investors
InvestorRounds
Bigbang Angels, Inc.Early Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 7, 2026

    Monthly visitors increased 836% MoM to 2.6K.

  • Mar 1, 2026

    Monthly visitors increased 242% MoM, from 80 to 274.

AIBLE Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AIBLE Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AIBLE Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range2
Year Founded2021
Last FundingNov 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?